Evidence map›Paper›PMID 33741499›Full record

ArticleTravel medicine and infectious disease

Learning from SARS and MERS: COVID-19 reinfection where do we stand?

Jaffar A Al-Tawfiq, Ali A Rabaan, Awad Al-Omari, Abbas Al Mutair, Manaf Al-Qahtani, Raghavendra Tirupathi

Abstract readEditorial
PubMed Full text at PMC Publisher
In one paragraph

Article in Travel medicine and infectious disease. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Jaffar A Al-TawfiqSpecialty Internal Medicine and Quality Department, Johns Hopkins Aramco Healthcare, Dhahran, Saudi Arabia; Division of Infectious Diseases, Department of Medicine, Indiana University School of Medicine, Indianapolis, IN, USA; Division of Infectious Diseases, Department of Medicine Johns Hopkins University School of Medicine, Baltimore, MD, USA. Electronic address: jaffar.tawfiq@jhah.com.
Ali A RabaanMolecular Diagnostic Laboratory, Johns Hopkins Aramco Healthcare, Dhahran, Saudi Arabia.
Awad Al-OmariResearch Center, Dr. Sulaiman Al Habib Medical Group, Riyadh, Saudi Arabia; College of Medicine, Alfaisal University, Riyadh, Saudi Arabia.
Abbas Al MutairResearch Center, Almoosa Specialist Hospital, Al Hasa, Saudi Arabia; College of Nursing, prince Nora University, Riyadh, Saudi Arabia; School of Nursing, Wollongong University, Australia.
Manaf Al-QahtaniBahrain National Taskforce to Combat COVID-19, Bahrain Defense Force Hospital, Bahrain.
Raghavendra TirupathiPenn State University School of Medicine, Hershey, PA, USA; Wellspan Chambersburg and Waynesboro (Pa.) Hospitals, Chambersburg, PA, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AdultChildCoronavirus InfectionsCOVID-19HumansMiddle East Respiratory Syndrome CoronavirusReinfectionSARS-CoV-2Severe Acute Respiratory SyndromeSevere acute respiratory syndrome-related coronavirusSpike Glycoprotein, CoronavirusSpike Glycoprotein, Coronavirus

Identifiers

PMID33741499
PMCPMC7962586

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.